LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible
Tirzepatide (Mounjaro, Zepbound) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. Whilst cold sensitivity is not listed as an adverse reaction in the Summary of Product Characteristics, some patients report feeling colder during treatment. This phenomenon is most commonly attributed to metabolic changes associated with weight loss, including reduced adipose tissue insulation and decreased caloric intake. Understanding why tirzepatide makes you cold, when it warrants medical review, and how to manage this symptom can help ensure safe, effective treatment whilst maintaining comfort and quality of life.
Quick Answer: Tirzepatide causes cold sensitivity primarily through metabolic changes associated with weight loss, including reduced adipose tissue insulation and decreased caloric intake, rather than a direct medication effect.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (Mounjaro) and for weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity (Zepbound). Cold sensitivity is not a listed adverse reaction in the UK Summary of Product Characteristics (SmPC); however, some patients report experiencing it anecdotally.
The most plausible explanation for feeling cold whilst taking tirzepatide relates to metabolic changes associated with weight loss. As the medication promotes significant reductions in body weight—with clinical trials showing 10-15% weight loss in type 2 diabetes and up to 20% in obesity trials—patients lose adipose tissue which serves as insulation. This reduction can diminish the body's ability to maintain warmth, particularly in cooler environments.
Additionally, caloric restriction often accompanies tirzepatide therapy. Reduced energy intake lowers the thermic effect of food—the energy expended during digestion and metabolism—which can contribute to feeling colder. The medication's effect on slowing gastric emptying and reducing appetite means patients typically consume fewer calories, further affecting metabolic heat production.
There is also emerging research suggesting that GLP-1 receptor agonists may influence brown adipose tissue activity and energy expenditure, though this mechanism remains speculative for tirzepatide and its clinical significance in causing cold sensitivity is not established. It is important to note that there is no evidence of a direct link between tirzepatide and thyroid dysfunction, though thyroid function should be assessed if clinically indicated, particularly if cold intolerance is accompanied by other symptoms.
Cold sensitivity whilst taking tirzepatide is not a recognised adverse reaction in clinical trials or the SmPC, but is anecdotally reported by some patients. When it occurs, it is likely related to weight loss and reduced caloric intake rather than a direct medication effect. It is not classified as a serious adverse effect and does not typically warrant discontinuation of therapy. Many patients report that this symptom is most pronounced during the initial months of treatment when weight loss is most rapid.
However, it is essential to distinguish between physiological cold sensitivity related to weight loss and symptoms that might indicate an underlying medical condition. Cold intolerance accompanied by other symptoms such as extreme fatigue, constipation, dry skin, hair loss, bradycardia (slow heart rate), or unexplained weight gain despite continued tirzepatide use could suggest thyroid dysfunction, particularly hypothyroidism.
Other common causes of cold sensitivity should also be considered, including iron-deficiency anaemia and vitamin B12 deficiency (particularly relevant for patients also taking metformin, which can reduce B12 absorption). Additionally, hypoglycaemia can cause cold, clammy sensations in patients also using insulin or sulfonylureas.
Severe or sudden onset cold intolerance, particularly if accompanied by fever, confusion, or signs of infection, requires prompt medical assessment. If cold sensitivity is associated with chest pain, severe breathlessness, or fainting, call 999 immediately as this could indicate cardiovascular concerns that need urgent evaluation. For less urgent concerns, contact NHS 111 for advice.
For the majority of patients, feeling colder than usual likely represents an adaptive response to body composition changes rather than a pathological process. Nonetheless, any persistent or concerning symptoms should be discussed with your GP or diabetes specialist nurse to ensure appropriate assessment and reassurance.
LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
Find out if you’re eligible
There are several practical strategies that can help manage cold sensitivity whilst continuing tirzepatide therapy. These approaches focus on maintaining body temperature, supporting metabolic function, and ensuring adequate nutrition during weight loss.
Clothing and environmental adjustments are often the most straightforward interventions. Wearing layers of clothing allows for better temperature regulation, and materials such as wool or thermal fabrics provide superior insulation. Keeping extremities warm with gloves, warm socks, and appropriate footwear is particularly important, as hands and feet are often most affected. Maintaining a comfortable ambient temperature at home and work, and using blankets can significantly improve comfort. If using heating devices, take care to avoid direct contact with skin, particularly if you have peripheral neuropathy, as reduced sensation increases the risk of burns.
Nutritional considerations play an important role in managing cold sensitivity. Whilst tirzepatide reduces appetite, it remains essential to consume adequate calories and nutrients to support metabolic function. Working with a registered dietitian (via NHS or British Dietetic Association) can help ensure that your reduced calorie intake still meets nutritional requirements, including adequate protein intake to preserve muscle mass during weight loss. Consuming warm foods and beverages throughout the day can provide both comfort and contribute to maintaining core body temperature. Ensuring adequate iron and vitamin B12 intake is also important, particularly if you are taking metformin.
Regular physical activity is beneficial for multiple reasons. Exercise generates heat, improves circulation, and helps maintain muscle mass—all of which contribute to better temperature regulation. The UK Chief Medical Officers' guidelines recommend that adults engage in at least 150 minutes of moderate-intensity activity weekly, which can be adapted to individual capabilities and preferences.
If cold sensitivity is particularly troublesome, discussing the rate of weight loss with your healthcare team may be appropriate. Reviewing your tirzepatide dose titration schedule as per the SmPC might allow for a slightly slower rate of weight reduction, which could improve tolerability whilst still achieving therapeutic goals.
Whilst mild cold sensitivity may occur during weight loss with tirzepatide, certain circumstances warrant medical review. Understanding when to seek advice ensures that any underlying conditions are identified and managed appropriately.
You should contact your GP or diabetes care team if you experience cold intolerance accompanied by:
Symptoms suggestive of thyroid dysfunction: extreme fatigue, significant hair loss, severe constipation, unexplained weight gain, depression, or cognitive difficulties
Cardiovascular symptoms: chest pain, palpitations, severe dizziness, fainting, or breathlessness (call 999 for severe symptoms)
Signs of infection: fever, chills, or feeling generally unwell, particularly if you have other risk factors or comorbidities
Severe or worsening symptoms: cold sensitivity that progressively worsens or becomes debilitating despite practical management strategies
Concerns about medication interactions: if you are taking other medications that might affect temperature regulation or metabolism
Your GP may arrange blood tests to assess thyroid function (TSH, free T4), full blood count (to exclude anaemia), ferritin, vitamin B12 (especially if you take metformin), and other relevant parameters depending on your clinical presentation. They will also review your overall diabetes management, medication dosing, and weight loss trajectory to ensure these remain appropriate.
For patients with pre-existing thyroid conditions, more frequent monitoring may be advisable, and any changes to thyroid medication should be discussed with your healthcare team. Similarly, individuals with cardiovascular disease or other significant comorbidities should maintain regular contact with their diabetes specialist to ensure comprehensive care.
It is important to remember that you should not discontinue tirzepatide without medical advice, as this medication provides significant benefits for glycaemic control and weight management. Your healthcare team can help balance the therapeutic benefits against any troublesome side effects and adjust your treatment plan accordingly.
If you suspect an adverse reaction to tirzepatide, you can report it through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk), which helps monitor medication safety in the UK.
Cold sensitivity on tirzepatide is not a recognised serious adverse effect and typically relates to weight loss rather than direct medication toxicity. However, if accompanied by symptoms such as extreme fatigue, hair loss, or unexplained weight gain, contact your GP to exclude thyroid dysfunction or other underlying conditions.
Practical strategies include wearing layered clothing with thermal fabrics, maintaining warm environments, consuming warm foods and beverages, ensuring adequate caloric and nutritional intake, and engaging in regular physical activity to generate heat and improve circulation.
Contact your GP if cold intolerance is accompanied by extreme fatigue, significant hair loss, severe constipation, unexplained weight gain, chest pain, palpitations, or if symptoms progressively worsen. Your GP may arrange blood tests to assess thyroid function, anaemia, and vitamin deficiencies.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.
